drugset / Trial / NCT00623714
Induced Sputum Study (0000-065)
RandomizedCrossoverDouble-blindTreatment
Summary
The primary goals of this study will be to implement innovative processing and detection assays to qualify induced sputum measurements of markers of allergen-induced airway inflammation. The results of this study are intended to form a platform to be used in the clinical development of novel asthma therapeutics.
Timeline
- Start
- 2008-01
- Primary completion
- 2009-02
- Completion
- 2009-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluticasone | Other / unclassified | 500 ug | Inhaled |